Nuclear translocation of urokinase-type plasminogen activator - sprookjes - yvandenbroek - TriplyDB

Nuclear translocation of urokinase-type plasminogen activator

Nuclear translocation of urokinase-type plasminogen activator

http://www.wikidata.org/entity/Q30482426

about

Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin Structure-function analysis of nucleolin and ErbB receptors interactions.Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice DNA damage-induced translocation of S100A11 into the nucleus regulates cell proliferation Surface expressed nucleolin is constantly induced in tumor cells to mediate calcium-dependent ligand internalization.Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type Aggregated low-density lipoprotein induce impairment of the cytoskeleton dynamics through urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor in human vascular smooth muscle cell.Nucleolin mediates the antiangiogenesis effect of the pseudopeptide N6L Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator.Novel mechanism regulating endothelial permeability via T-cadherin-dependent VE-cadherin phosphorylation and clathrin-mediated endocytosis.Disrupting the oncogenic synergism between nucleolin and Ras results in cell growth inhibition and cell death Urokinase-type plasminogen activator (uPA) induces pulmonary microvascular endothelial permeability through low density lipoprotein receptor-related protein (LRP)-dependent activation of endothelial nitric-oxide synthase.Expression of Nucleolin Affects Microtubule Dynamics.Fibulin-5 binds urokinase-type plasminogen activator and mediates urokinase-stimulated β1-integrin-dependent cell migration.Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.Multifunctional roles of urokinase plasminogen activator (uPA) in cancer stemness and chemoresistance of pancreatic cancer.Human tissue factor pathway inhibitor-2 is internalized by cells and translocated to the nucleus by the importin system.Senescence, apoptosis, and stem cell biology: the rationale for an expanded view of intracrine action Emerging drugs for the therapy of primary and post essential thrombocythemia, post polycythemia vera myelofibrosis.Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues.Transformation of a chronic myeloproliferative neoplasm to acute myelogenous leukemia: does anything work?Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma.Enhancing FTS (Salirasib) efficiency via combinatorial treatment.Current status of biomarker and targeted nanoparticle development: The precision oncology approach for pancreatic cancer therapy.The pseudopeptide HB-19 binds to cell surface nucleolin and inhibits angiogenesis.Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis.Copine-7 binds to the cell surface receptor, nucleolin, and regulates ciliogenesis and Dspp expression during odontoblast differentiation.Urokinase-type plasminogen activator inhibits efferocytosis of neutrophils.Proteomic analysis reveals a proteolytic feedback loop in murine seminal fluid.The nuclear translocation of endostatin is mediated by its receptor nucleolin in endothelial cells.

P2860

Q28472975-718A7D37-7AFE-4BB6-A862-84ABDC600D64 Q33478425-1B9CD2AC-D67F-4352-B8C3-973D44C628BF Q33614407-7D4C214A-5319-4B48-BBE5-5A2CCF05498D Q33774606-33528EAF-A276-4D55-A60D-C4DE2B443B08 Q33784401-2CD21CAB-0F44-470F-B257-6FA82A7DA976 Q33980633-AB290368-8A6D-458B-83EC-A8EF5B7BC6E8 Q34385625-56183D58-2D6C-4F06-B7AC-EB7AF5AB927E Q34475097-8E37826D-54FC-4F9B-8B92-FDE5B47F95C6 Q34606581-554FB537-4929-49FB-B7E2-88E0BAC4BE55 Q34656695-25870E39-7B1B-4DAD-8437-DDC34B492DD6 Q35005500-709C1863-B930-40F1-9E14-D10F7A699018 Q35067747-F10E0E51-CFBE-4166-8A82-28102991924D Q36053965-345D85A0-0F28-4E86-8F6E-E7A1A3D49ACC Q36112952-EDA6D912-DEEA-4F36-87FC-CFECF29ACB65 Q37098900-76F618C0-E6FF-4934-A9E9-3BBC4A432137 Q37131462-77B77E45-9ED4-470D-A1A4-65251D8A282E Q37152354-5519E576-F901-41FC-819B-F1959357C143 Q37372370-FFBCD150-AE83-4B8B-923B-EA20FBF1EF3C Q37529843-84B0E79C-5AFD-49A8-82AC-4F0650D8E819 Q37566249-B180FE5F-6F79-4574-9F61-EE6D3AC63147 Q37968531-90D4E418-227A-41F5-B168-294A9AF363CE Q38303924-88C032F2-CD32-496F-8B2D-AD4B7147385D Q38367291-E7A6F263-4BEC-44E1-B657-2AD089A34352 Q39028976-534BEAE3-344C-4003-A675-D8BBEC77FCE7 Q39232685-B4079AD2-60C2-4404-934D-DDF9E5FC3F30 Q39368829-0C053971-F6B0-4B1A-830F-42AA7D4F447C Q41197179-D6C12015-DF2B-4F9E-B4D9-585D11C25770 Q41973656-99D5337D-B774-4FE0-9AF0-B6E47BD238FD Q50739041-51367BCA-B24E-43F3-8647-053EECC1E2AA Q54077957-FED4648D-2838-4390-BEFB-DF3F338CEFF4

P2860

Nuclear translocation of urokinase-type plasminogen activator

http://www.wikidata.org/entity/Q30482426

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Nuclear translocation of urokinase-type plasminogen activator

@ast

Nuclear translocation of urokinase-type plasminogen activator

@en

type

label

Nuclear translocation of urokinase-type plasminogen activator

@ast

Nuclear translocation of urokinase-type plasminogen activator

@en

prefLabel

Nuclear translocation of urokinase-type plasminogen activator

@ast

Nuclear translocation of urokinase-type plasminogen activator

@en

P1433

Q30482426-253C1169-8269-4E7C-AC04-582782051907

P1476

Q30482426-6620123D-1FB9-48C5-A680-7D3AE9BC60AC

P2093

Q30482426-18A0E7F7-1E36-4543-8420-6CEE91301C61

Q30482426-2BE456A9-B155-405C-A922-1282B3F4B48F

Q30482426-47337480-FB39-41C9-BF40-87B6611B40B1

Q30482426-505D065F-41D8-4976-9BC7-5F8968A9A9C8

Q30482426-51AAAD96-6592-4214-B55A-9373B07598B8

Q30482426-6E463EFB-BC98-4864-9A01-197C81F04BF1

Q30482426-A8FC7683-38BC-428B-913A-4B58E969C59F

Q30482426-C117A014-CB9C-4A59-B377-585F1C2BBF53

Q30482426-CAFB2484-07AB-449F-82EB-62E0DCDDE73E

Q30482426-F04BF0E8-AB16-4AE8-8308-A8BAE5336879

P2860

Q30482426-00D2C2AB-36F5-43F9-AC36-3FFFAF305123

Q30482426-05E8FA14-1D8F-4D5F-948D-85A41BBB6A33

Q30482426-0F68817D-4D43-49C1-A37F-DF26CF72CF82

Q30482426-143EDD27-B195-4267-95DA-1C5F183FF7DF

Q30482426-14DB40FD-D419-433A-B708-DB4C25A04567

Q30482426-27DBC97D-D4A6-498B-908E-CCDB8A412AF9

Q30482426-29D8603F-81EC-4209-A361-81D19A1B77B2

Q30482426-2ACCBA68-D23A-4D7A-BE0E-954108ABDBF5

Q30482426-31F245F1-8340-46B1-BC09-7C7344AAA1ED

Q30482426-33C35BF9-9F3F-4B49-BD3D-22277A867E92

P304

Q30482426-F985BD31-3DD8-4C6B-89F9-5C27C315DE01

P31

Q30482426-CC97B9D7-66A0-441C-AFE4-EC35A17AFD47

P356

Q30482426-53000D20-BAE3-469F-80C0-A58D69A64991

P407

Q30482426-004CBD03-DCCD-4262-A9DA-D6F5EFFADBF8

P433

Q30482426-37766070-B906-44CA-86DA-679B08AD7330

P478

Q30482426-C85023DF-008E-40ED-A8F6-D140911337FC

P50

Q30482426-FA5E9B2D-5826-4AFA-A4D2-434B3377CB85

P577

Q30482426-55E97258-7D4E-47B8-AA7F-6A6277C1E526

P698

Q30482426-30B59371-4695-4811-94A9-983D39002131

P932

Q30482426-89D61623-61A0-4C2D-8235-368A77AF29BF

P356

BLOOD-2007-07-104455

P1433

P1476

Nuclear translocation of urokinase-type plasminogen activator

@en

P2093

Abd Al-Roof Higazi

http://www.w3.org/2001/XMLSchema#string

Alice Kuo

http://www.w3.org/2001/XMLSchema#string

Douglas B Cines

http://www.w3.org/2001/XMLSchema#string

Inna Dumler

http://www.w3.org/2001/XMLSchema#string

Khalil Bdeir

http://www.w3.org/2001/XMLSchema#string

Serge Yarovoi

http://www.w3.org/2001/XMLSchema#string

Sergei Tkachuk

http://www.w3.org/2001/XMLSchema#string

Sergei Zaitsev

http://www.w3.org/2001/XMLSchema#string

Tatiana Lebedeva

http://www.w3.org/2001/XMLSchema#string

Victoria Stepanova

http://www.w3.org/2001/XMLSchema#string

P2860

The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxis

Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis

The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin

Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin

Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

The urokinase plasminogen activator receptor in the regulation of the actin cytoskeleton and cell motility

The anti-HIV cytokine midkine binds the cell surface-expressed nucleolin as a low affinity receptor

The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis

Pleiotrophin inhibits HIV infection by binding the cell surface-expressed nucleolin

P304

100-110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2007-07-104455

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

Michael S. Marks

P577

2008-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18337556

http://www.w3.org/2001/XMLSchema#string

P932

2435680

http://www.w3.org/2001/XMLSchema#string